Minerva Surgical Inc. (UTRS)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Company Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.

The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.

Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.

The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical Inc.
Minerva Surgical Inc. logo
Country United States
IPO Date Oct 22, 2021
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 174
CEO Darrin Hammers

Contact Details

Address:
4255 Burton Drive
Santa Clara, California
United States
Website https://minervasurgical.com

Stock Details

Ticker Symbol UTRS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001452965
CUSIP Number 60343F106
ISIN Number US60343F1066
Employer ID 26-3422906
SIC Code 3841

Key Executives

Name Position
Darrin Hammers Chief Executive Officer
Brent Palmisano Chief Commercial Officer
Dr. Evgueni V. Skalnyi M.D. Chief Medical Officer
Erik Reese Vice President of Sales
Greg Simbro Vice President of Finance
Joanne Long Vice President of Corporate Controller
Wendy Bowman Vice President of Human Resources

Latest SEC Filings

Date Type Title
Jan 04, 2024 15-12G Filing
Dec 26, 2023 25 Filing
Dec 26, 2023 S-8 POS Filing
Dec 15, 2023 8-K Current Report
Nov 13, 2023 10-Q Quarterly Report
Nov 13, 2023 8-K Current Report
Nov 02, 2023 SC 13E3/A [Amend] Filing
Nov 02, 2023 8-K Current Report
Oct 13, 2023 8-K Current Report
Sep 29, 2023 8-K Current Report